Colorectal tumors: The histology report

Digestive and Liver Disease

Volumn 43, Issue SUPPL. 4, 2011, Pages

  Lanza, Giovanni ^a   Messerini, Luca ^b   Gafà, Roberta ^c   Risio, Mauro ^d  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^d CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

Adenocarcinoma; Adenoma; Colorectal; GIPAD report; KRAS; Microsatellite instability; Polyposis syndromes; Serrated polyps

Indexed keywords

ADENOMATOUS POLYP; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; COLON POLYPOSIS; COLORECTAL ADENOMA; COLORECTAL TUMOR; HISTOPATHOLOGY; HUMAN; MEDULLARY CARCINOMA; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; RECTUM POLYP; SQUAMOUS CELL CARCINOMA; VIRUS RELEASE;

ADENOMA; ADENOMATOUS POLYPS; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTESTINAL MUCOSA; INTESTINAL POLYPOSIS; INTESTINAL POLYPS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATHOLOGY; PROGNOSIS; SPECIMEN HANDLING;

EID: 79953202502     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(11)60590-2     Document Type: Article

References (56)

1. Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum. World Health Organization classification of tumours. Pathology and genetics. Tumors of the digestive system 2000, 103-119. IARC Press, Lyon, France. Hamilton (Ed.).
2. Dixon MF Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002, 51:130-131.
3. Quirke P, Risio M, Lambert R, et al. Quality assurance in pathology in colorectal cancer screening and diagnosis - European recommendations. Virchows Arch 2011, 458:1-19.
4. Soetikno RM, Kaltenbach T, Rouse RV, et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. Jama 2008, 299:1027-1035.
5. Haggitt RC, Glotzbach RE, Soffer EE, et al. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985, 89:328-336.
6. Coverlizza S, Risio M, Ferrari A, et al. Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer 1989, 64:1937-1947.
7. Ueno H, Mochizuki H, Hashiguchi Y, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004, 127:385-394.
8. Hassan C, Zullo A, Risio M, et al. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum 2005, 48:1588-1596.
9. Snover DC Serrated polyps of the large intestine. Semin Diagn Pathol 2005, 22:301-308.
10. O'Brien MJ, Yang S., Huang C.S., et al. The serrated polyp pathway to colorectal carcinoma. Diagn Histopathol 2008, 14:78-93.
11. Farris AB, Misdraji J, Srivastava A, et al. Sessile Serrated Adenoma: Challenging Discrimination From Other Serrated Colonic Polyps. Am J Surg Pathol 2008, 32:30-35.
12. Torlakovic EE, Gomez JD, Driman DK, et al. Sessile Serrated Adenoma (SSA) vs. Traditional Serrated Adenoma (TSA). Am J Surg Pathol 2008, 32:21-29.
13. Hornick JL, Odze RD Polyps of the large intestine. Surgical pathology of the GI tract, liver, biliary tract, and pancreas 2009, 481-533. Saunders, Philadelphia. R.D. Odze (Ed.).
14. Schreibman IR, Baker M, Amos C, et al. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005, 100:476-490.
15. McGarrity TJ, Kulin HE, Zaino RJ Peutz-Jeghers syndrome. Am J Gastroenterol 2000, 95:596-604.
16. van Lier MG, Wagner A, Mathus-Vliegen EM, et al. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol 2010, 105:1258-1264. author reply, 1265.
17. Galiatsatos P, Foulkes WD Familial adenomatous polyposis. Am J Gastroenterol 2006, 101:385-398.
18. Soravia C, Berk T, Madlensky L, et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 1998, 62:1290-1301.
19. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003, 348:791-799.
20. Burt R, Jass JR Hyperplastic polyposis. World Health Organization classification of tumors. Pathology and genetics. Tumours of the digestive system 2000, 135-136. IARC Press, Lyon, France. S.R. Hamilton (Ed.).
21. Redston M Epithelial neoplasms of the large intestine. Surgical pathology of the GI tract, liver, biliary tract, and pancreas 2009, 597-637. Saunders, Philadelphia. R.D. Odze (Ed.).
22. Jass JR Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007, 50:113-130.
23. Gafà R, Maestri I, Matteuzzi M, et al. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer 2000, 89:2025-2037.
24. Jass JR, O'Brien J, Riddell RH, et al. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma: Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 2008, 129:13-23.
25. Lanza G, Gafà R, Matteuzzi M, et al. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival. J Clin Oncol 1999, 17:2429-2438.
26. Washington MK, Berlin J, Branton P, et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 2009, 133:1539-1551.
27. Williams GT, Quirke P, Sheperd NA Dataset for Colorectal Cancer 2007, 1-27. The Royal College of Pathologists. http://www.rcpath.org, 2nd ed.
28. Sobin LH, Gospodarowicz MK, Wittekind CH TNM Classification of Malignant Tumours 2009, 100-105. UICC, Wiley-Blackwell. Seventh Edition.
29. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual 2009, 143-159. Springer. Seventh Edition.
30. Shepherd NA, Baxter KJ, Love SB The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997, 112:1096-1102.
31. Gunderson LL, Jessup JM, Sargent DJ, et al. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol 2010, 28:256-263.
32. Gunderson LL, Jessup JM, Sargent DJ, et al. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010, 28:264-271.
33. Nagtegaal ID, Quirke P What is the role for the circumferential margin in the modern treatment of rectal cancer?. J Clin Oncol 2008, 26:303-312.
34. West NP, Morris EJ, Rotimi O, et al. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 2008, 9:857-865.
35. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007, 99:433-441.
36. Morris EJ, Maughan NJ, Forman D, et al. Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist. J Clin Oncol 2007, 25:2573-2579.
37. Bilimoria KY, Bentrem DJ, Stewart AK, et al. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst 2008, 100:1310-1317.
38. Rosenberg R, Friederichs J, Schuster T, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a singlecenter analysis of 3,026 patients over a 25-year time period. Ann Surg 2008, 248:968-978.
39. Messerini L, Cianchi F, Cortesini C, et al. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma. Hum Pathol 2006, 37:1259-1267.
40. Puppa G, Ueno H, Kayahara M, et al. Tumor deposits are encountered in advanced colorectal cancer and other adenocarcinomas: an expanded classification with implications for colorectal cancer staging system including a unifying concept of in-transit metastases. Mod Pathol 2009, 22:410-415.
41. Quirke P, Williams GT, Ectors N, et al. The future of the TNM staging system in colorectal cancer: time for a debate?. Lancet Oncol 2007, 8:651-657.
42. Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005, 47:141-146.
43. Dworak O, Keilholz L, Hoffmann A Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997, 12:19-23.
44. Prall F Tumour budding in colorectal carcinoma. Histopathology 2007, 50:151-162.
45. Guidoboni M, Gafà R, Viel A, et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 2001, 159:297-304.
46. Zlobec I, Lugli A Prognostic and predictive factors in colorectal cancer. J Clin Pathol 2008, 61:561-569.
47. Walther A, Johnstone E, Swanton C, et al. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009, 9:489-499.
48. Monzon FA, Ogino S, Hammond ME, et al. The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer. Arch Pathol Lab Med 2009, 133:1600-1606.
49. van Krieken JH, Jung A, Kirchner T, et al. KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch 2008, 453:417-431.
50. de la Chapelle A, Hampel H Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol 2010, 28:3380-3387.
51. Shia J Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohisto-chemistry. J Mol Diagn 2008, 10:293-300.
52. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96:261-268.
53. Bessa X, Balleste B, Andreu M, et al. A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening. Clin Gastroenterol Hepatol 2008, 6:206-214.
54. Popat S, Hubner R, Houlston RS Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005, 23:609-618.
55. Lanza G, Gafà R, Santini A, et al. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol 2006, 24:2359-2367.
56. Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 2010, 28:3219-3226.